Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma.

Leuk Lymphoma 2016 08 13;57(8):1831-8. Epub 2016 Jan 13.

a Department of Medicine I, Intensive Care Unit 13i2 , Medical University of Vienna , Vienna , Austria ;

Some patients with diffuse large B-cell lymphoma (DLBCL) require intensive care unit (ICU) admission prior to or during chemotherapy. We analyzed all unscheduled ICU admissions in 331 consecutive patients (18-93 years) with newly diagnosed DLBCL. Thirty-seven patients (11.2%) required ICU treatment primarily due to hemodynamic (37.8%) or respiratory failure (24.3%). Bulky disease and high IPI score were predictive of ICU admission in the early course. ICU and hospital survival was 75.7% and 70.3%, respectively. Overall survival in ICU patients with newly diagnosed DLBCL was worse compared to non-ICU-patients (40.7% vs. 72.7% at two years). However, survival of high-risk patients (IPI 3-5), continuous complete remission, and disease-free survival did not differ. Post-ICU survival was poor in patients with relapsed/refractory DLBCL (0.1-10 months). Our observations favor unrestricted ICU support in DLBCL patients undergoing first-line therapy. ICU referral of patients with refractory/relapsed disease must be evaluated in the context of the hematologic prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1106537DOI Listing
August 2016
80 Reads

Publication Analysis

Top Keywords

intensive care
12
patients
9
large b-cell
8
patients diffuse
8
diagnosed dlbcl
8
newly diagnosed
8
icu admission
8
icu
8
b-cell lymphoma
8
diffuse large
8
care unit
8
survival
6
dlbcl
5
243% bulky
4
compared non-icu-patients
4
worse compared
4
dlbcl worse
4
failure 243%
4
patients newly
4
407% 727%
4

Similar Publications